Zeidan AM - Search Results

1

What lies within: novel strategies in immunotherapy for non-small cell lung cancer.

Forde PM, Reiss KA, Zeidan AM, Brahmer JR. Forde PM, et al. Among authors: zeidan am. Oncologist. 2013;18(11):1203-13. doi: 10.1634/theoncologist.2013-0171. Epub 2013 Oct 8. Oncologist. 2013. PMID: 24105749 Free PMC article. Review.

2

Sequential occurrence of a splenic marginal zone lymphoma, extranodal MALT lymphoma, and Hodgkin lymphoma.

Zeidan A, Faltas B, Forde P, Subhawong A, Bello C, Bolaños-Meade J. Zeidan A, et al. Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):496-8. doi: 10.1016/j.clml.2013.04.004. Epub 2013 Jun 5. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23747079 Free PMC article. No abstract available.

3

Venous thromboembolism prophylaxis in hematopoietic stem cell transplantation patients: an international web-based survey of healthcare providers.

Zeidan AM, Wellman J, Forde PM, Bolaños-Meade J, Streiff MB. Zeidan AM, et al. J Thromb Thrombolysis. 2014 May;37(4):524-6. doi: 10.1007/s11239-013-1002-0. J Thromb Thrombolysis. 2014. PMID: 24092259 Free PMC article. No abstract available.

4

HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation.

Zeidan AM, Forde PM, Symons H, Chen A, Smith BD, Pratz K, Carraway H, Gladstone DE, Fuchs EJ, Luznik L, Jones RJ, Bolaños-Meade J. Zeidan AM, et al. Biol Blood Marrow Transplant. 2014 Mar;20(3):314-8. doi: 10.1016/j.bbmt.2013.11.020. Epub 2013 Dec 1. Biol Blood Marrow Transplant. 2014. PMID: 24296490 Free PMC article.

5

Beyond hypomethylating agents failure in patients with myelodysplastic syndromes.

Zeidan AM, Kharfan-Dabaja MA, Komrokji RS. Zeidan AM, et al. Curr Opin Hematol. 2014 Mar;21(2):123-30. doi: 10.1097/MOH.0000000000000016. Curr Opin Hematol. 2014. PMID: 24335709 Free PMC article. Review.

6

Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?

Nazha A, Sekeres MA, Gore SD, Zeidan AM. Nazha A, et al. Among authors: zeidan am. Oncologist. 2015 Sep;20(9):1069-76. doi: 10.1634/theoncologist.2015-0067. Epub 2015 Jul 20. Oncologist. 2015. PMID: 26194858 Free PMC article. Review.

7

[No title available]

[No authors listed] [No authors listed] PMID: 36163969

8

Lenalidomide performance in the real world: patterns of use and effectiveness in a Medicare population with myelodysplastic syndromes.

Zeidan AM, Gore SD, McNally DL, Baer MR, Hendrick F, Mahmoud D, Davidoff AJ. Zeidan AM, et al. Cancer. 2013 Nov 1;119(21):3870-8. doi: 10.1002/cncr.28298. Epub 2013 Aug 6. Cancer. 2013. PMID: 23922173 Free PMC article.

9

Current therapy of myelodysplastic syndromes.

Zeidan AM, Linhares Y, Gore SD. Zeidan AM, et al. Blood Rev. 2013 Sep;27(5):243-59. doi: 10.1016/j.blre.2013.07.003. Epub 2013 Jul 27. Blood Rev. 2013. PMID: 23954262 Free PMC article. Review.

10

There's risk, and then there's risk: The latest clinical prognostic risk stratification models in myelodysplastic syndromes.

Zeidan AM, Komrokji RS. Zeidan AM, et al. Curr Hematol Malig Rep. 2013 Dec;8(4):351-60. doi: 10.1007/s11899-013-0172-3. Curr Hematol Malig Rep. 2013. PMID: 23979829 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page